drug

fitusiran

1 story · latest Oct 30, 2026

Follow fitusiran. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Mar 2025 · NDA219019
Brand: Qfitlia
Code: SAR439774
Trials: 3 registered trials in coverage

Relationships

Developed by Sanofi

Timeline

Sanofi registers three-country OPTIMUS RISK cardiovascular cohort studies in ASCVD patients

Oct 30Weekly roundup, 6 itemsfitusiran lunsekimigUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.